Literature DB >> 20574708

Lower-lobe shrinkage relative to total lung volume in collagen vascular diseases.

M Watanabe1, T Igishi, N Burioka, J Kurai, Y Fukuoka, K Kato, A Yamasaki, Y Hasegawa, R Okazaki, E Shimizu.   

Abstract

PURPOSE: It has been reported that the prognosis differs between patients who have collagen vascular diseaseassociated interstitial pneumonia (CVD-IP) and those with idiopathic IP (IIP). In this study, chest computed tomography (CT) findings were compared between patients with CVD-IP and IIP.
MATERIALS AND METHODS: A retrospective analysis was performed of 47 consecutive patients (23 with CVD-IP and 24 with IIP). The lower-lobe volume (LLV), total lung volume (TLV), and their ratio (LLV/TLV) were determined by volumetry using three-dimensional computed tomography (CT).
RESULTS: There was no significant difference of the LLV/TLV ratio between the CVD-IP and IIP groups. However, the LLV/TLV ratio was <0.33 in 9/23 patients with CVD-IP versus 2/24 patients with IIP, and there was a significant difference in the percentage of patients with a ratio<0.33 between the CVD-IP and IIP groups (p = 0.01). The LLV/TLV ratio was not influenced by the severity of lung disease.
CONCLUSIONS: Measuring the LLV/TLV ratio by threedimensional CT can help distinguish between CVD-IP and IIP at initial diagnosis, especially in patients with CVD-IP who have pulmonary involvement before other organ diseases and symptoms caused by CVD.

Entities:  

Mesh:

Year:  2010        PMID: 20574708     DOI: 10.1007/s11547-010-0555-7

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  43 in total

1.  Shrinking lung in primary Sjögren's syndrome.

Authors:  A Tavoni; C Vitali; G Cirigliano; S Frigelli; G Stampacchia; S Bombardieri
Journal:  Arthritis Rheum       Date:  1999-10

Review 2.  Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria.

Authors:  M Mosca; R Neri; S Bombardieri
Journal:  Clin Exp Rheumatol       Date:  1999 Sep-Oct       Impact factor: 4.473

Review 3.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

4.  Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both?

Authors:  Andrea Doria; Marta Mosca; Pier Franca Gambari; Stefano Bombardieri
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

5.  Muscle Disease in systemic lupus erythematosus: a study of its nature, frequency and cause.

Authors:  D A Isenber; M L Snaith
Journal:  J Rheumatol       Date:  1981 Nov-Dec       Impact factor: 4.666

6.  Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus.

Authors:  Mohammed Y Karim; Luis C Miranda; Colin M Tench; Patrick A Gordon; David P D'cruz; Munther A Khamashta; Graham R V Hughes
Journal:  Semin Arthritis Rheum       Date:  2002-04       Impact factor: 5.532

7.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

8.  The "shrinking lung syndrome" in SLE, treatment with theophylline.

Authors:  S Van Veen; A J Peeters; P J Sterk; F C Breedveld
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

9.  Diaphragm function and lung involvement in systemic lupus erythematosus.

Authors:  C J Gibson; J P Edmonds; G R Hughes
Journal:  Am J Med       Date:  1977-12       Impact factor: 4.965

10.  Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.

Authors:  A U Wells; P Cullinan; D M Hansell; M B Rubens; C M Black; A J Newman-Taylor; R M Du Bois
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.